Dr. Clinton Canal
Associate Professor of Pharmaceutical Sciences
Education
- B.S., Psychology; Minor, Philosophy, University of Florida
- Ph.D., Neuroscience, University of Illinois, Urbana-Champaign
Research Background and Interests
Serotonin Receptor Pharmacology and Neurobiology. Dr. Canal’s research utilizes in vitro molecular pharmacology, in vivo behavioral pharmacology, and in vivo/ex vivo neurobiology to understand central mechanisms and functions of unique serotonin (5-HT) receptors.
He focuses on how these receptors modulate molecular systems affected by central nervous system disorders, aiming to guide drug discovery for 5-HT receptor targets. His work has led to the development of novel compounds for treating various conditions, including autism spectrum disorders (targeting 5-HT1A and 5-HT7), Fragile X syndrome (targeting 5-HT7), psychotic disorders (targeting 5-HT2A and 5-HT2C), and substance use disorders (targeting 5-HT2A and 5-HT2C).
Courses
- PHA 334 Foundations in Pharmacology and Immunology
- PHA 375 Comprehensive Patient Centered Care I
- PHA 546 Nervous System Pharmacotherapy
- PHA 548 Project Development
- PHA 549 Introduction to Research
- PHA 744 Scientific Writing
- PHA 799 Masters Thesis Research
- PHA 846 Current Topics in Pharmaceutical Sciences
- PHA 847 Molecular and Behavioral Neuropharmacology
- PHA 899 Doctoral Research